Amended Statement of Ownership (sc 13g/a)
February 14 2017 - 6:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment 1)
(Name of Issuer) TRACON Pharmaceuticals, Inc.
(Title of Class of Securities) Common Stock
(CUSIP Number) 89237H100
(Date of Event Which Requires Filing of this Statement) December 30, 2016
Check the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ]Rule 13d-1(b)
[ X ]Rule 13d-1(c)
[ ]Rule 13d-1(d)
CUSIP No. 89237H100
1.Names of Reporting Persons.
Laurence W.Lytton
2. Check the Appropriate Box if a Member of a Group (See Instructions)
a)..........................................................................
(b)..........................................................................
3.SEC Use Only
4.Citizenship or Place of Organization
USA
5.Sole Voting Power 1,278,371
6.Shared Voting Power 117,328
7.Sole Dispositive Power 1,278,371
8.Shared Dispositive Power 117,328
9.Aggregate Amount Beneficially Owned by Each Reporting
Person 1,395,699
10.Check if the Aggregate Amount in Row (9) Excludes Certain Shares
(See Instructions).................................
11.Percent of Class Represented by Amount in Row (9)
8.7%
12.Type of Reporting Person (See Instructions)
IN
Item 1.
(a)Name of Issuer TRACON Pharmaceuticals, Inc.
(b)Address of Issuer's Principal Executive Offices
8910 University Center Lane, Suite 700
San Diego, California 92122
Item 2.
(a)Name of Person Filing Laurence W. Lytton
(b)Address of Principal Business Office or, if none, Residence
467 CPW
N.Y., NY 10025
(c)Citizenship USA
(d)Title of Class of Securities Common
(e)CUSIP Number 89237H100
Item 3. not applicable
Item 4.Ownership.
(a)Amount beneficially owned: 1,395,699 shares consisting of
1,230,308 shares held by the reporting person, 48,063 held in
the AWL Family LLC, 69,528 held in the IKL Trust, 18,700 held
in the KLL Family Trust, 10,000 held in the Lytton-Kambara
Foundation, and 19,100 shares held in other related accounts.
(b)Percent of class: 8.7%
(c)Number of shares as to which the person has:
(i)Sole power to vote or to direct the vote 1,278,371.
(ii)Shared power to vote or to direct the vote 117,328.
(iii)Sole power to dispose or to direct the disposition of 1,278,371.
(iv)Shared power to dispose or to direct the disposition of 117,328.
Item 5.Ownership of Five Percent or Less of a Class:
Not applicable
Item 6.Ownership of More than Five Percent on Behalf of Another Person.
Not applicable
Item 7.Identification and Classification of the Subsidiary Which
Acquired the Security Being Reported on By the Parent Holding Company
Not applicable
Item 8.Identification and Classification of Members of the Group
Not applicable
Item 9.Notice of Dissolution of Group
Not applicable
Item 10.Certification
By signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are not held
for the purpose of or with the effect of changing or influencing the control
of the issuer of the securities and were not acquired and are not held
in connection with or as a participant in any transaction having that
purpose or effect.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.
___02/13/17____________________________
Date
____s/ Laurence W. Lytton____________________________
Signature
_____Laurence W. Lytton___________________________
Name/Title
|
TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
From Aug 2024 to Sep 2024
TRACON Pharmaceuticals (NASDAQ:TCON)
Historical Stock Chart
From Sep 2023 to Sep 2024